These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 15607729

  • 1. No inhibition of IL-27 signaling by soluble gp130.
    Scheller J, Schuster B, Hölscher C, Yoshimoto T, Rose-John S.
    Biochem Biophys Res Commun; 2005 Jan 28; 326(4):724-8. PubMed ID: 15607729
    [Abstract] [Full Text] [Related]

  • 2. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL, Ward LD, Tu GF, Fabri LJ, Ji H, Yasukawa K, Simpson RJ.
    Growth Factors; 1999 Jan 28; 16(4):265-78. PubMed ID: 10427501
    [Abstract] [Full Text] [Related]

  • 3. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G, Küster A, Hemmann U, Keul R, Horsten U, Martens A, Graeve L, Wijdenes J, Heinrich PC.
    J Immunol; 1998 Dec 01; 161(11):6347-55. PubMed ID: 9834125
    [Abstract] [Full Text] [Related]

  • 4. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
    Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schürmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF.
    Nat Med; 2000 May 01; 6(5):583-8. PubMed ID: 10802717
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway.
    Liu XH, Kirschenbaum A, Lu M, Yao S, Klausner A, Preston C, Holland JF, Levine AC.
    Biochem Biophys Res Commun; 2002 Jan 11; 290(1):249-55. PubMed ID: 11779161
    [Abstract] [Full Text] [Related]

  • 6. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
    Klein C, Wüstefeld T, Assmus U, Roskams T, Rose-John S, Müller M, Manns MP, Ernst M, Trautwein C.
    J Clin Invest; 2005 Apr 11; 115(4):860-9. PubMed ID: 15761498
    [Abstract] [Full Text] [Related]

  • 7. Development of a monoclonal antibody-based enzyme-linked immunoabsorbent assay for the binding of gp130 to the IL-6/IL-6R complex and its competitive inhibition.
    Scheller J, Kovaleva M, Rabe B, Eichler J, Kallen KJ, Rose-John S.
    J Immunol Methods; 2004 Aug 11; 291(1-2):93-100. PubMed ID: 15345308
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
    Selander KS, Li L, Watson L, Merrell M, Dahmen H, Heinrich PC, Müller-Newen G, Harris KW.
    Cancer Res; 2004 Oct 01; 64(19):6924-33. PubMed ID: 15466183
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP, Mani JC, Liautard J, Klein B, Brochier J.
    Eur Cytokine Netw; 1999 Mar 01; 10(1):43-8. PubMed ID: 10210772
    [Abstract] [Full Text] [Related]

  • 10. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T, Müllberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S.
    Eur J Biochem; 2001 Jan 01; 268(1):160-7. PubMed ID: 11121117
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
    Mees ST, Toellner S, Marx K, Faendrich F, Kallen KJ, Schroeder J, Haier J, Kahlke V.
    J Surg Res; 2009 Dec 01; 157(2):235-42. PubMed ID: 19589542
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
    Rose-John S, Scheller J, Elson G, Jones SA.
    J Leukoc Biol; 2006 Aug 01; 80(2):227-36. PubMed ID: 16707558
    [Abstract] [Full Text] [Related]

  • 13. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
    Hirano T, Ishihara K, Hibi M.
    Oncogene; 2000 May 15; 19(21):2548-56. PubMed ID: 10851053
    [Abstract] [Full Text] [Related]

  • 14. STAT3 is dispensable for maintenance of self-renewal in nonhuman primate embryonic stem cells.
    Sumi T, Fujimoto Y, Nakatsuji N, Suemori H.
    Stem Cells; 2004 May 15; 22(5):861-72. PubMed ID: 15342949
    [Abstract] [Full Text] [Related]

  • 15. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
    Peters M, Blinn G, Solem F, Fischer M, Meyer zum Büschenfelde KH, Rose-John S.
    J Immunol; 1998 Oct 01; 161(7):3575-81. PubMed ID: 9759879
    [Abstract] [Full Text] [Related]

  • 16. IL-6 transsignaling: the in vivo consequences.
    Jones SA, Richards PJ, Scheller J, Rose-John S.
    J Interferon Cytokine Res; 2005 May 01; 25(5):241-53. PubMed ID: 15871661
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow culture.
    Sammons J, Ahmed N, Khokher MA, Hassan HT.
    Stem Cells; 2000 May 01; 18(3):214-9. PubMed ID: 10840075
    [Abstract] [Full Text] [Related]

  • 18. [Abnormal gp130 signaling and autoimmune disease].
    Ishihara K, Atsumi T.
    Tanpakushitsu Kakusan Koso; 2002 Dec 01; 47(16 Suppl):2336-42. PubMed ID: 12518458
    [No Abstract] [Full Text] [Related]

  • 19. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
    Skiniotis G, Boulanger MJ, Garcia KC, Walz T.
    Nat Struct Mol Biol; 2005 Jun 01; 12(6):545-51. PubMed ID: 15895091
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.
    Mitsuyama K, Matsumoto S, Masuda J, Yamasakii H, Kuwaki K, Takedatsu H, Sata M.
    Anticancer Res; 2007 Jun 01; 27(6A):3749-56. PubMed ID: 17970038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.